BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12511565)

  • 1. The NFY transcription factor inhibits von Willebrand factor promoter activation in non-endothelial cells through recruitment of histone deacetylases.
    Peng Y; Jahroudi N
    J Biol Chem; 2003 Mar; 278(10):8385-94. PubMed ID: 12511565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NFY transcription factor functions as a repressor and activator of the von Willebrand factor promoter.
    Peng Y; Jahroudi N
    Blood; 2002 Apr; 99(7):2408-17. PubMed ID: 11895773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NFY transcription factor mediates induction of the von Willebrand factor promoter by irradiation.
    Bertagna A; Jahroudi N
    Thromb Haemost; 2001 May; 85(5):837-44. PubMed ID: 11372677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone H1-like protein participates in endothelial cell-specific activation of the von Willebrand factor promoter.
    Wang X; Peng Y; Ma Y; Jahroudi N
    Blood; 2004 Sep; 104(6):1725-32. PubMed ID: 15150074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cells of different organs exhibit heterogeneity in von Willebrand factor expression in response to hypoxia.
    Mojiri A; Alavi P; Lorenzana Carrillo MA; Nakhaei-Nejad M; Sergi CM; Thebaud B; Aird WC; Jahroudi N
    Atherosclerosis; 2019 Mar; 282():1-10. PubMed ID: 30665023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repressors NFI and NFY participate in organ-specific regulation of von Willebrand factor promoter activity in transgenic mice.
    Nassiri M; Liu J; Kulak S; Uwiera RR; Aird WC; Ballermann BJ; Jahroudi N
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1423-9. PubMed ID: 20431063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An NF1-like protein functions as a repressor of the von Willebrand factor promoter.
    Jahroudi N; Ardekani AM; Greenberger JS
    J Biol Chem; 1996 Aug; 271(35):21413-21. PubMed ID: 8702923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irradiation modulates association of NF-Y with histone-modifying cofactors PCAF and HDAC.
    Peng Y; Stewart D; Li W; Hawkins M; Kulak S; Ballermann B; Jahroudi N
    Oncogene; 2007 Nov; 26(54):7576-83. PubMed ID: 17599060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene.
    Schwachtgen JL; Janel N; Barek L; Duterque-Coquillaud M; Ghysdael J; Meyer D; Kerbiriou-Nabias D
    Oncogene; 1997 Dec; 15(25):3091-102. PubMed ID: 9444957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
    Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
    Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequences in intron 51 of the von Willebrand factor gene target promoter activation to a subset of lung endothelial cells in transgenic mice.
    Kleinschmidt AM; Nassiri M; Stitt MS; Wasserloos K; Watkins SC; Pitt BR; Jahroudi N
    J Biol Chem; 2008 Feb; 283(5):2741-50. PubMed ID: 18048367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial-cell-specific regulation of von Willebrand factor gene expression.
    Jahroudi N; Lynch DC
    Mol Cell Biol; 1994 Feb; 14(2):999-1008. PubMed ID: 7507210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor.
    Zhou J; Hernandez G; Tu SW; Scholes J; Chen H; Tseng CP; Hsieh JT
    Cancer Res; 2005 Jul; 65(14):6089-96. PubMed ID: 16024609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell type-specific regulation of von Willebrand factor expression by the E4BP4 transcriptional repressor.
    Hough C; Cuthbert CD; Notley C; Brown C; Hegadorn C; Berber E; Lillicrap D
    Blood; 2005 Feb; 105(4):1531-9. PubMed ID: 15498853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms for transcriptional regulation of human high-affinity IgE receptor beta-chain gene induced by GM-CSF.
    Takahashi K; Hayashi N; Kaminogawa S; Ra C
    J Immunol; 2006 Oct; 177(7):4605-11. PubMed ID: 16982898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase A-dependent recruitment of RNA polymerase II, C/EBP beta and NF-Y to the rat GTP cyclohydrolase I proximal promoter occurs without alterations in histone acetylation.
    Kapatos G; Vunnava P; Wu Y
    J Neurochem; 2007 May; 101(4):1119-33. PubMed ID: 17394555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y; Dufau ML
    J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oct-1 is involved in the transcriptional repression of the von willebrand factor gene promoter.
    Schwachtgen JL; Remacle JE; Janel N; Brys R; Huylebroeck D; Meyer D; Kerbiriou-Nabias D
    Blood; 1998 Aug; 92(4):1247-58. PubMed ID: 9694713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-specific expression of aquaporin-5 (Aqp5) in alveolar epithelium is directed by GATA6/Sp1 via histone acetylation.
    Flodby P; Li C; Liu Y; Wang H; Rieger ME; Minoo P; Crandall ED; Ann DK; Borok Z; Zhou B
    Sci Rep; 2017 Jun; 7(1):3473. PubMed ID: 28615712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.